Clinical Trial Design

  • China
  • |
  • Guatemala
  • |
  • South Korea
  • |
  • Spain

Dr. Brose is the global co-PI of DECISION, the pivotal international multi-institutional Phase III trial of sorafenib for patients with iodine refractory differentiated thyroid cancer. In this capacity, she conducts training sessions in clinical trial design at sites worldwide including in the US, South Korea, China and Spain.